Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Cocaine Dependence
Interventions
DRUG

Vigabatrin

crystalline drug dissolved in orange juice, dosage escalates from 500 mg twice daily to 1.5 g twice daily over a 3 week period. This dose is maintained for 4 weeks and then tapered to zero over the next two weeks

DRUG

Placebo

orange juice is administered twice daily in containers indistinguishable from the treatment arm.

BEHAVIORAL

Group therapy

Participants attend group sessions once a week

Trial Locations (1)

11560

Clinica Integral de Tratamiento Contra las Adicciones SA de CV, Mexico City

Sponsors
All Listed Sponsors
collaborator

Catalyst Pharmaceuticals, Inc.

INDUSTRY

lead

NYU Langone Health

OTHER

NCT00527683 - Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence | Biotech Hunter | Biotech Hunter